The State of Texas Top Legal Officer Sues Tylenol Producers Concerning Autism Spectrum Assertions

Texas Attorney General Ken Paxton is taking legal action against the producers of acetaminophen, asserting the corporations concealed safety concerns that the drug presented to children's brain development.

The lawsuit arrives thirty days after Former President Trump advocated an unsubstantiated connection between consuming acetaminophen - referred to as acetaminophen - while pregnant and autism in offspring.

Paxton is taking legal action against Johnson & Johnson, which previously sold the drug, the sole analgesic recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he claimed they "betrayed America by making money from suffering and promoting medication regardless of the dangers."

The company states there is insufficient reliable data tying Tylenol to autism.

"These manufacturers lied for decades, knowingly endangering countless individuals to boost earnings," Paxton, from the Republican party, said.

The manufacturer said in a statement that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the potential impact that could have on the health of women and children in America."

On its online platform, Kenvue also said it had "continuously evaluated the relevant science and there is insufficient valid information that shows a proven link between using acetaminophen and autism spectrum disorder."

Organizations acting on behalf of medical professionals and health professionals agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the key substance in Tylenol - is a restricted selection for pregnant women to treat pain and fever, which can present major wellness concerns if left untreated.

"In more than two decades of studies on the use of acetaminophen in gestation, no reliable research has definitively established that the usage of paracetamol in any period of gestation leads to brain development issues in offspring," the group commented.

The lawsuit cites recent announcements from the previous government in claiming the medication is allegedly unsafe.

Recently, the former president caused concern from health experts when he advised women during pregnancy to "resist strongly" not to consume Tylenol when ill.

The US Food and Drug Administration then issued a notice that medical professionals should contemplate reducing the use of Tylenol, while also declaring that "a causal relationship" between the drug and autism in young ones has not been established.

The Health Department head Kennedy, who supervises the FDA, had pledged in spring to initiate "extensive scientific investigation" that would determine the source of autism spectrum disorder in a matter of months.

But specialists advised that finding a sole reason of autism spectrum disorder - believed by scientists to be the result of a complex mix of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and disability that affects how persons experience and interact with the environment, and is diagnosed using doctors' observations.

In his legal document, the attorney general - a Trump ally who is running for the Senate - alleges the manufacturer and Johnson & Johnson "willfully ignored and tried to quiet the research" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the firms "eliminate any promotional materials" that asserts Tylenol is safe for expectant mothers.

The court case mirrors the concerns of a group of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in recently.

A federal judge dismissed the case, stating investigations from the plaintiffs' authorities was not conclusive.